Tony Tang - Equilibar

Tony Tang

Director of Operations, Mechanical Engineer

Zero Flow Patent

As Director of Operations, Tony Tang oversees much of Equilibar’s day-to-day operations and is involved in design, quality system management, and broad-based consultation and support. Tony works closely with clients to understand their challenges and develop the best solution for their applications while ensuring quality product delivery. He is a member of Equilibar’s tactical leadership team.

“Typically, I gravitate to research applications where the user’s end goal is something unique and new to an industry or process,” he says. “I’m intrigued by how clients in all sorts of research backgrounds find clever ways to use Equilibar technology.”

Tony has more than ten years of experience at Equilibar and is one of the inventors named on the Zero Flow back pressure regulator patent. He is a knowledgeable resource for process control design and has a natural talent for managing large projects without missing the small details. His calm approach helps keep everyone productive. “I believe it’s important to try not to get frustrated with problems because the majority of our job here at Equilibar is trying to solve problems to get the client a solution.”

Away from work, Tony is active in multiple outdoor activities including rock climbing and mountain biking. He is involved with several conservation organizations in the region.

Tony’s areas of interest include catalysis, fuel cell technology, and core analysis. He earned B.S. and M.S. degrees in Mechanical Engineering from North Carolina State University.

Equilibar News
cover of PI magazine

Process Instrumentation cover story: Ryan Heffner discusses pharmaceutical fluid control

The November issue of Process Instrumentation magazine features a cover article by Ryan Heffner, single use technology manager for Equilibar, that provides a comprehensive overview of fluid control options for the fast-changing pharmaceutical industry. Researchers responding to the COVID epidemic dramatically accelerated the rate of change in the pharmaceutical industry as they developed vaccines and Read More

Read More